Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 5Endocrine 3Dermatologic 3CNS 3Thoracic 2Gynecologic 2Genitourinary 2Gastrointestinal 2Breast 2Sarcoma 1Plasma cell 1Other hematologic neoplasm 1NET 1Lymphoid 1

Conditions

Neuroendocrine Tumors 7Adenoma, Islet Cell 2Uveal Melanoma 1Thyroid Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Prostatic Neoplasms 1Pheochromocytoma 1Paraganglioma 1Non functioning pancreatic endocrine tumor 1Neoplasm Metastasis 1Multiple Sclerosis 1Metastatic Digestive System Neuroendocrine Tumor G1 1Melanoma 1Breast Neoplasms 1Brain Neoplasms 1Advanced Lung Neuroendocrine Tumor 1Adrenocortical Carcinoma 1Adenocarcinoma of Lung 1

Interventions

Magnetic Resonance Spectroscopy 3Fluorodeoxyglucose F18 3FAPI-46 2romidepsin 1repotrectinib 1regorafenib 1pralsetinib 1pembrolizumab 1fludarabine phosphate 1alectinib 1Specimen Handling 1Quality of Life 1Patient Reported Outcome Measures 1Nivolumab 1Molecular Diagnostic Techniques 1Lactones 1Interleukin-13 1Immunotherapy 1Drug Therapy 1Depsipeptides 1Cyclophosphamide 1Cryosurgery 1Clinical Trials, Phase II as Topic 1Biopsy 1Biological Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Thyroid Neoplasms × Specimen Handling × NET × Clear all
NCT04119024 2026-03-17

Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors

Stanford University

Phase 1 Recruiting
18 enrolled
BreastCNSDermatologicEndocrineHead & NeckNETThoracic

Adenocarcinoma of Lung, Squamous Cell Carcinoma of Head and Neck, Uveal Melanoma, Breast Neoplasms, Adenoma, Islet Cell, Melanoma, Neoplasm Metastasis, Paraganglioma, Pheochromocytoma, Thyroid Neoplasms, Adrenocortical Carcinoma, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡